NCT00074321View on ClinicalTrials.gov

Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

July 31, 2010

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

irinotecan hydrochloride

Given IV

DRUG

oxaliplatin

Given IV

DRUG

capecitabine

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00074321 - Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter